Isolation and characterisation of human pulmonary microvascular endothelial cells from patients with severe emphysema by Laura S Mackay et al.
Mackay et al. Respiratory Research 2013, 14:23
http://respiratory-research.com/content/14/1/23RESEARCH Open AccessIsolation and characterisation of human
pulmonary microvascular endothelial cells from
patients with severe emphysema
Laura S Mackay1*, Sara Dodd2, Iain G Dougall2, Wendy Tomlinson2, James Lordan1, Andrew J Fisher1
and Paul A Corris1Abstract
Background: Loss of the pulmonary microvasculature in the pathogenesis of emphysema has been put forward as
a credible alternative to the classical inflammatory cell driven proteolysis hypothesis. Mechanistic studies in this area
have to date employed animal models, immortalised cell lines, primary endothelial cells isolated from large
pulmonary arteries and non-pulmonary tissues and normal human pulmonary microvascular endothelial cells.
Although these studies have increased our understanding of endothelial cell function, their relevance to
mechanisms in emphysema is questionable. Here we report a successful technique to isolate and characterise
primary cultures of pulmonary microvascular endothelial cells from individuals with severe emphysema.
Methods: A lobe of emphysematous lung tissue removed at the time of lung transplantation surgery was obtained
from 14 patients with severe end-stage disease. The pleura, large airways and large blood vessels were excised and
contaminating macrophages and neutrophils flushed from the peripheral lung tissue before digestion with
collagenase. Endothelial cells were purified from the cell mixture via selection with CD31 and UEA-1 magnetic
beads and characterised by confocal microscopy and flow cytometry.
Results: Successful isolation was achieved from 10 (71%) of 14 emphysematous lungs. Endothelial cells exhibited a
classical cobblestone morphology with high expression of endothelial cell markers (CD31) and low expression of
mesenchymal markers (CD90, αSMA and fibronectin). E-selectin (CD62E) was inducible in a proportion of the
endothelial cells following stimulation with TNFα, confirming that these cells were of microvascular origin.
Conclusions: Emphysematous lungs removed at the time of transplantation can yield large numbers of pulmonary
microvasculature endothelial cells of high purity. These cells provide a valuable research tool to investigate cellular
mechanisms in the pulmonary microvasculature relevant to the pathogenesis of emphysema.
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Lung endothelial cell injury is hypothesised to be a key
event in the pathogenesis of emphysema [1,2] and forms
an increasingly credible “microvascular hypothesis” as an
alternative to the classical hypothesis in which inflam-
matory cells are seen as the orchestrators of tissue de-
struction [3]. A number of models have been employed
to investigate the role of the pulmonary endothelium* Correspondence: l.s.mackay@ncl.ac.uk
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reproduction in any medium, provided the orranging from in-vitro cellular systems to in-vivo animal
models. Early cellular studies were based on large vessel
endothelial cells, typically from the main pulmonary
trunk, or used human umbilical vein endothelial cells
(HUVECs) as a surrogate for the lung microvasculature
[4]. Immortalised human cells lines have also been used
as they provide a stable cell population and are easily
expanded for use in a range of assays. However such
cells, which evade the normal controls within the cell
cycle [5], do not always express markers characteristic
of the tissue in which they originated [6,7] and their
responses ex vivo may not reflect the true in vivo responseLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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monary microvascular endothelial cells, which form the
luminal barrier of intra-acinar arterioles and venules and
the alveolar capillary network have also been isolated from
bovine [10], ovine [11] and rodent lungs [12] which pro-
vide more biologically relevant models in which endothe-
lial cell responses to injury can be studied. Although these
systems may not accurately reflect human cellular re-
sponses, they have facilitated the development of methods
to effectively isolate lung microvascular endothelial cells
(LMVECs) from normal human tissue [13-15] and such
cells are now available from a number of commercial
suppliers. These commercially available primary LMVECs
have the advantage of being fully compliant with regula-
tory legislation and information regarding patient age and
in some cases smoking status is available. However, it is
impossible to determine whether the individuals from
whom cells were isolated had normal pulmonary function
or whether they had any pre-existing lung disease. The
ability to compare cellular responses in disease free
individuals with those who have developed severe disease
is very attractive given the observation that only about
20% of individuals who smoke develop emphysema [16]
suggesting that the pathology reflects an individual’s
disordered cellular response to the injury rather than the
injury per se. Thus, comparing how lung microvascular
endothelial cells from susceptible individuals behave in
contrast to lung microvascular endothelial cells isolated
from individuals free from emphysema may provide unique
insights into the cellular responses to cigarette smoke
which lead to emphysema.
In this study we present, to our knowledge, the first
report of successful isolation of LMVECs from well
characterised patients with severe emphysema. The cells
from emphysematous lung were then characterised and
compared with LMVECs from pathologically normal
lung tissue derived from patients undergoing isolated
lung cancer resection surgery and with commercially
available LMVECs.
Subjects
Ethical approval to obtain emphysematous tissue from
patients undergoing lung transplantation was granted by
the Northumberland Local Research Ethics Committee
(REC reference 06/Q0902/57). All patients awaiting lung
transplantation for emphysema at Freeman Hospital,
Newcastle Upon Tyne, UK were invited to take part in
the study. Patients gave informed consent to donate
their explanted lung for research purposes. The study
was performed in accordance with ICH-GCP.
Ethical approval to obtain normal tissue from patients
undergoing lobectomy/ pneumonectomy was granted by
County Durham and Tees Valley 2 Research Ethics Com-
mittee (REC reference 09/H0908/35). Patients betweenthe ages of 18–75 years undergoing lobectomy/ pneumo-
nectomy with no evidence of emphysema/ fibrosis on radi-
ology or pulmonary function testing were invited to take
part in the study. The study was performed in accordance
with ICH-GCP.
Clinical data including age, body mass index and pul-
monary function tests were obtained from each individ-
ual who donated tissue. Smoking status and smoking
history from each patient was also obtained. Those with
emphysema were also categorized according to the
updated GOLD criteria (2003) [17,18].
Methods
Obtaining diseased lung tissue
At the time of transplantation, the lung was inspected to
confirm the macroscopic pathology was in keeping with
pre-operative diagnosis and to exclude any unexpected
pathology. A lobe or part of a lobe was then dissected
and stored at 4°C until clinical pathology assessment
(which was typically performed within 12 hours). Following
routine clinical pathology, blocks of tissue were fixed in
neutral buffered formalin for investigative pathology. The
remaining tissue (typically around 50 g) was used immed-
iately for cell isolation.
Obtaining normal tissue
The operating surgeon performing lobectomy for suspected
lung cancer identified a wedge of normal tissue within the
tissue removed at surgery but discrete from the tumor
resection margins. This was dissected from the remaining
tissue and tumour and placed in media. Both samples were
transported to clinical pathology where the wedge sample
was inspected and once confirmed to be free from disease,
was used immediately for cell isolation. Tissue samples
ranged from 5-30 g.
Cell isolation
Contaminating macrophages were removed via repeated
inflation of the tissue with sterile phosphate buffered sa-
line (PBS). The pleura, visible arterioles, bronchioles and
venules were then dissected to prevent overgrowth with
mesothelial and epithelial cells and reduce contamination
with macrovascular endothelial cells. The remaining pe-
ripheral lung tissue was washed in RPMI containing 10%
fetal calf serum (FCS) and 1% penicillin streptomycin and
amphotericin (PSA) and finely chopped (1-2 mm2 pieces).
The tissue pieces were then washed on a 40 μm filter to
remove red blood cells before incubation with 0.2% type II
collagenase (CLS-2, Worthington) in RPMI containing
0.1% bovine serum albumin (BSA) for 2 hours on a roller
at room temperature. Following incubation, the suspen-
sion was filtered on a 400-500 μm mesh and then a
100 μm sterile filter. The filtrate was centrifuged (250 g for
5 minutes). The supernatant was discarded and resulting
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(Promocell) containing 1% PSA. An automated cell count
was performed and cells plated onto flasks pre-coated
with 0.2% gelatin (w/v in MilliQ water, coated for 30 min
at room temperature, excess gelatin solution was removed
before cell addition) at approximately 10,000 cells/cm2.
Cells were cultured at 37°C in the presence of 5% CO2.
Non-adherent cells were removed after 24 hours in cul-
ture by gentle flushing with PBS over the flasks. MV2
media was replaced every 3–4 days.
Endothelial cell purification
When the cells reached approximately 80% confluence,
they were passaged using cell dissociation solution
(Sigma) and separated from any contaminating fibroblast
and epithelial cells using CD31 Dynal beads (Invitrogen)
and pre-prepared Ulex europaeus agglutinin-1 (UEA-1)
coated Dynal beads. UEA-1 binds to the α-L-Fucosyl
residues of glycoprotein present on the surface of human
microvascular endothelial cells, thus in conjugation with
magnetic beads allows the selection of endothelial cells
from a mixed cell suspension [19]. The cells were re-
suspended in PBS containing 0.1% BSA and 2 mM
EDTA (Dynal Buffer) and 25 ul each of CD31 Dynal beads
and UEA-1 coated beads were added. The cells/beads
mixture was incubated on a rocker at 4°C for 20 minutes,
to minimise non-specific binding. The beads were then
washed in Dynal buffer and placed in a Dynal magnet.
The bead negative fluid was discarded. After repeated
washing and magnetic separation, the bead positive cells
were counted and plated on 0.2% gelatin coated tissue cul-
ture flasks at approximately 3,000 cells/cm2 and incubated
at 37°C in the presence of 5% CO2. Bead separation was
performed over 3–5 passages of the cells until pure
cobblestone cultures were obtained.
Cryopreservation of cells
When cultures appeared free from contaminating cells,
cells were cryopreserved in MV2 media (Promocell)
containing 1% DMSO (Sigma). All emphysema cultures
were cryopreserved and then later reanimated for char-
acterisation and explorative experiments.
Commercial human pulmonary microvascular endothelial
cells
Commercial LMVECs were purchased from Promocell
(C12281) and cultured after reanimation at 37°C with 5%
CO2 using endothelial growth MV2 media (Promocell)
supplemented with 1% PSA (as used with cells isolated
from patients).
Mycoplasma testing
All isolated cells and commercial cells were routinely
tested for mycoplasma infection using Myco Alert kits(LT07-218, Lonza). Testing was carried out on all isolated
cells prior to experimentation and on commercial cells on
a monthly basis. The cells showed no evidence of myco-
plasma infection.
Phase contrast microscopy
Cells were grown to confluence and images taken on
Canon image shot.
Confocal microscopy
Cells were cultured on 18 mm glass coverslips in 12 well
plates. At confluence, cells were washed in PBS and fixed
in freshly prepared paraformaldehyde (4%). Following
fixation, cells were quenched in 100 mM glycine for 30 -
minutes, before permeabilisation in PBS Triton X-100
(1% v/v) for 20 minutes. Following permeabilisation, cells
were washed with PBS containing 0.2% tween (0.2%
PBST) and PBS. After blocking with 5% BSA for 60 -
minutes, coverslips were incubated with primary anti-
bodies (CD31 (Sc53411, Santa Cruz) Fibronectin (F3648,
Sigma), αSMA, (F3777, Sigma) in 0.5% BSA overnight at
4°C. Cells were then washed as before with 0.2% PBST
and PBS. Fluorochrome pre-conjugated secondary anti-
bodies (FITC: Mouse (F2012) and TRITC: Rabbit (T6778),
Sigma) were then applied (0.5% BSA) for 60 minutes and
then washed in 0.2% PBST and PBS. The cells were then
mounted with DAPI mounting medium (H-1200, Vector
Labs) and viewed on a Leica Sp2UV laser scanning con-
focal microscope and analysed with software from Leica
(LCS 2.61).
Flow cytometry
Initial experiments to determine optimal concentrations
of antibodies were conducted using microvascular endo-
thelial cells purchased from Promocell. Each cell popula-
tion was stained using the same conditions.
CD31/CD90 characterisation
Cells at 70-80% confluence were used in all characterisa-
tion experiments. Cells were harvested using cell dissoci-
ation solution (Sigma) with approximately 100,000 cells
per 100 ul used for each stain. Cells were washed and
re-suspended in 100 ul PBS and incubated with FITC
conjugated CD31 (#555445 BD Bioscience) and PE cy5
conjugated CD90 (# 555597 BD Bioscience) for 30 -
minutes at 4°C, to reduce non-specific binding. Cells
were then washed in PBS, centrifuged at 250 g for 4 -
minutes, re-suspended in 200 ul PBS and analysed on
FACS Scan (Becton Dickinson).
CD62E characterisation
Cells were grown in 6 well plates and at 70-80% conflu-
ence were treated with TNFα (1 ng/ml). Following treat-
ment cells were harvested using cell dissociation solution
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stain. Cells were washed and re-suspended in 100 ul PBS
and incubated with APC conjugated CD62E (E-selectin)
(#551144 BD Bioscience) for 30 minutes at 4°C, to reduce
non-specific binding. Cells were then washed in PBS,
centrifuged at 250 g for 4 minutes, re-suspended in 200 ul
PBS and analysed on FACS Scan.
Results
Cell isolation was attempted from lung tissue obtained
from 16 patients (11 emphysema, 3 α1 anti-trypsin
related emphysema and 2 normals) and was successful
in 10 (71%) of the emphysema donors. Table 1 shows
the baseline characteristics and clinical data from the 16
individuals in whom cell isolation was attempted. In
addition to diagnosis, smoking history, body mass index
(BMI) and spirometry measures were included. Those
patients with emphysema were categorised according to
disease severity based upon the GOLD classification.
Cell yield from successful cultures is documented.
Phase contrast microscopy of isolated cells
Prior to the first passage, cells in culture were a mixed
population of elongated cells and cobblestone cells. Fol-
lowing the initial bead separation, at the first passage, the
bead positive cells displayed cobblestone morphology andTable 1 Patient characteristics and cell yield
Patient
No:






46 28.7 15 1
2 F Emphysema 54 21.5 30 1
3 F Emphysema 53 20.9 30 2
4 F Emphysema 51 20.8 30 2
5 F Emphysema 46 20.2 20 2
6 M Emphysema 58 22.7 35 1
7 F Emphysema 59 21.8 25 3
8 M Emphysema 44 23 15 1
9 F Emphysema 60 28.3 20 2
10 M Emphysema 45 21.3 27 2
11 M Emphysema 55 20.8 55 1
12 F A1AT
emphysema
40 26.1 25 1
13 M Emphysema 47 22.3 30 1
14 M A1AT
emphysema
52 21.2 15 2
15 F Normal 68 - 15 1
16 F Normal 65 - 40 8grew in a monolayer in colonies (Figure 1a). Beads could
also be seen attached to many of the cobblestone cells. In
contrast, the bead negative cells (Figure 1b) were elongated
and spindle shaped and grew in sheets, becoming con-
fluent more quickly. At the early passages a mixed popula-
tion of cells was still present within areas of the bead
positive fraction (Figure 1c) with some elongated cells
growing together with cobblestone cells. For this reason,
repeated bead separation was performed until cultures
contained only cobblestone cells.Characterisation of cells via confocal microscopy
Cells stained positively for the endothelial cell surface
marker CD31 (FITC green) (Figure 2a-c). Cells dis-
played contact inhibition with the formation of a lattice
of tight junctions. The bead negative cells showed no
CD31 staining (Figure 2d). The mesenchymal marker
alpha smooth muscle actin (αSMA) (TRITC red) was ab-
sent on CD31 positive cells (Figure 2a-c) but was present
on the CD31 negative fraction (Figure 2d) in an
elongated spindle shaped pattern (red). CD31 positive
cells (Figure 2a-c) also had very low levels of the intra-
cellular matrix protein fibronectin, in contrast to CD31
negative cells (Figure 2d) which demonstrated high








Cell yield (passage number
at cryopreservation)
8 133 15 IV 1.9 ×106 cells (passage 4)
0 178 - IV 2.5 ×106 cells (passage 4)
2 131 32 IV 9.4 ×106 cells (passage 5)
5.4 ×106 cells (passage 4)
8 150 33 IV 5.6 ×106 cells (passage 4)
28.8 ×106 cells (passage 5)
1 150 43 IV Unsuccessful
5 130 46 IV Unsuccessful
4 155 38 III 12 ×106 cells (passage 4)
4 138 69 IV 3.2 ×106 cells (passage 4)
21.5 ×106 cells (passage 6)
6 95 25 IV 5.2 ×106 cells (passage 6)
6 156 42 IV 5.4 ×106 cells (passage 4)
7 130 24 IV Unsuccessful
6 136 33 IV 18.2 ×106 cells (passage 6)
7 150 42 IV 13.9 ×106 cells (passage 4)
2 127 71 IV Unsuccessful
04 - - N/A 1 ×106 cells (passage 3)
0 - - N/A Unsuccessful
Figure 1 Phase contrast microscopy of cells following the initial bead separation (Patient 5). a) Cobblestone cells growing in colonies.
b) Bead negative fraction showing elongated spindle cells. c) Areas showing a mixture of cobblestone cells and more elongated cells.
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LMVECs (Promocell) and dermal fibroblasts (gifted by
ICM, Newcastle University) were used to determine the
optimal concentration of each antibody (CD90 and CD31)
required for flow cytometry characterisation experiments
(Figure 3a-e). Once concentrations for each antibody alone
were determined, a second set of experiments were con-
ducted to determine the optimal concentration of CD31
(1 ul) and CD90 (0.5 ul) to separate a mixed population of
LMVECs and fibroblasts (Figure 3f). Following these pre-
liminary experiments, cells from patients with emphysema
and a normal donor were characterised using the estab-
lished protocol (Figure 4). The cell populations isolated
from all donors were characterised by high expression of
CD31 and low expression of CD90 (Figure 4). Cells from
the normal donor (patient 15) were characterised at pas-
sage 2, as evidenced by the slightly lower number of CD31
positive cells (78%).
CD62E (E-Selectin) expression on isolated CD31 posi-
tive cells at baseline and after stimulation with TNFα
was also investigated. CD62E is a cell surface adhesion
molecule involved in leukocyte trafficking that is absent
on microvascular endothelial cells but is inducible upon
cytokine stimulation [20]. Capillaries do not express
CD62E at baseline or upon activation. We therefore
hypothesised that the isolated CD31 positive cells would
be CD62E negative at baseline and that a proportionrepresenting microvascular cells excluding capillaries
would become CD62E positive upon stimulation while a
second subpopulation representing the capillaries would
remain CD62E negative. Commercially available LMVECs
were first investigated to determine the concentration
of TNFα, CD62 antibody and appropriate time course
required. Approximately 40-50% cells stained positively
for CD62E at a low concentration of TNFα (1 ng/ml) for
1 hour and 24 hours, across a range of antibody concen-
tration (2.5 ul-10 ul) (Figure 5). A similar percentage of
cells were positive for CD62E with higher concentrations
of TNFα (2-8 ng/ml) (data not shown).
CD31 positive cells from 3 patients with emphysema
were selected at random and thereafter stimulated with
1 ng/ml TNFα for 1 hour and stained for CD62E to inves-
tigate whether these cells were microvascular in origin.
The emphysema cells demonstrated minimal baseline
CD62E expression (<5%) with a rightward shift in re-
sponse to TNFα stimulation at 1 hour with approximately
30% cells staining positively for CD62E (Figure 6). Cells
from one emphysema donor (patient 8) were used to fur-
ther investigate CD62E expression on these isolated cells
at further time points (2, 4 and 8 hours) (Figure 7). There
was similar induction of CD62E expression that became
maximal at 8 hours and then fell at 24 hours to levels
similar to previous experiments. Due to the precious na-









Figure 2 Detection of immunocytochemical markers via confocal microscopy (CD31: FITC green, aSMA: TRITC red, DAPI: blue). LMVECs
(Promocell) (a) were compared to LMVECs isolated from patient 8 with emphysema (b) and LMVECs isolated from excess normal tissue (patient
15) (c). Cellular expression on these cells was compared with that on the bead negative fraction from excess normal tissue (d). All images were
taken at X 63 magnification.
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positive cells isolated were negative at baseline for CD62E
but inducible in a proportion of cells, we had confirmed
these to be of microvascular origin.
Discussion
Microvascular endothelial cells have been isolated previ-
ously from a variety of organs including human lung,
however we present the first report of a method to suc-
cessfully isolate such cells from emphysematous lung
tissue. This method allows ex vivo study of a cell popula-
tion which may be key in the pathogenesis of emphy-
sema. Importantly, the method we have developed allows
the isolation and culture of large numbers of human
LMVECs (Table 1) with a high success rate (71%). Fur-
thermore, the cells could be successfully expanded,cryopreserved and later re-animated for use in future
studies. Cells showed stability of phenotype to passage 7.
Certain steps were critical to the success of this method.
The tissue could be stored for up to 24 hours from the
time of transplant until histopathological processing, how-
ever once processing began, cell isolation had to follow
immediately otherwise it was unsuccessful. Careful dissec-
tion of the large vessels and removal of pleura to prevent
overgrowth by contaminating mesothelial cells was also
vital. Daily observation of cell numbers and doubling time
was also required in order to determine the optimal time
for bead separation as time between each passage differed
between donors and did not appear related to passage
number or disease severity.
Endothelial cell extraction employed bead separation with
magnetic dynal beads for CD31 (endothelial cell surface
Figure 3 Representative flow cytometry scatter plots showing CD31 and CD90 staining. Unstained mixed cell population, LMVECs
(Promocell) and fibroblasts (a). Endothelial cells stain positively for CD31 (b) and negatively for CD90 (c). Fibroblasts stain negatively for CD31 (d)
but strongly positive for CD90 (e). Mixed Endothelial cells and fibroblasts show separation of the cell populations (f).
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researchers have previously reported difficulties when using
CD31 dynal beads, hypothesising that disruption of cell sur-
face CD31 by beads inhibited the cell to cell interactions
required for successful growth in culture [20]. We did not
encounter such problems, although doubling time immedi-
ately post bead separation was more prolonged.
By passage 4–6, cells appeared free from contaminating
spindle shaped cells and were characterised according to a
standard protocol developed using commercially available
cells. The commercially available cells were used both
to set a standard against which the cells isolated could be
characterised and to ensure that precious isolated primary
cells were not used for optimisation of experimental
protocols. Comparing the cells isolated from patients
with emphysema to those isolated from lung resection
operations and commercially available cells provided a
further control.
The immunocytochemical detection of cell surface
markers via confocal microscopy confirmed the isolated
cells were endothelial, staining positively for the endothelialmarker CD31 with weak/absent staining for mesenchymal
markers. This was further confirmed by flow cytometry,
with cells staining positively for the endothelial cell marker
CD31 and negatively for the fibroblast marker CD90. These
approaches proved very cell efficient, requiring only small
numbers of cells for full characterisation (~1×106), thus
preserving large numbers of cells for use in future studies.
Plant derived lectins have previously been employed to
differentiate between microvascular and macrovascular
endothelial cells [21]. We encountered difficulties with
non-specific binding of the lectins Griffonia (Bandeiraea)
simplicifolia and Helix pomatia previously used to dif-
ferentiate between microvascular and macrovascular
endothelial cells respectively both on single cells and
on paraffin embedded tissue. As a result, we investigated
E-selectin (CD62E) expression as an alternative method
to differentiate between microvascular and macrovascu-
lar endothelial cells. E-Selectin (CD62E) and P-Selectin
(CD62P) are receptor molecules for monocytes and
neutrophils that are expressed on activated endothelial
cells [22]. CD62E, in contrast to CD62P which is stored in
Figure 4 (See legend on next page.)
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Figure 4 (a) Representative flow cytometry scatter plots depicting CD31:CD90 characterisation of cells isolated from patients with








Figure 5 Representative flow cytometry scatter plots showing the response of LMVECs (Promocell) to TNFα (1 ng/ml) stimulation at
1 and 24 hours as detected by differing concentration of CD62E antibody (2.5-10 ul).
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Figure 6 Representative scatter plots showing the response of microvascular endothelial cells from patients with emphysema to TNFα
(1 ng/ml) stimulation for 1 hour as measured via CD62E immunostaining via flow cytometry.
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ally induced on microvascular endothelial cells in response
to cytokine stimulation [20]. Capillaries are not thought to
express CD62E [23,24]. Thus quiescent microvascular
cells do not express CD62E but following activation
intraacinar arterioles and venules express CD62E, while




































Figure 7 Percentage CD62E positive cells (patient 8)
determined via flow cytometry (Mean +/− SD; n = 3) following
treatment with TNFα (1 ng/ml). Untreated cells did not express
CD62E. The percentage of treated cells that expressed CD62E was
maximal at 8 hours before falling at 24 hours. The profile observed is
most likely the result of TNFα induced transcriptional induction at
early time points and cleavage of CD62E from the cell surface
at 24 hours.isolated CD31 positive cells showed very low (<5%)
staining for CD62E at baseline. In response to stimulation
with TNFα, there was inducible staining in around 30-50%
of the isolated cells at 1 hour. Inducible CD62E in re-
sponse to TNFα suggests these endothelial cells are micro-
vascular. Furthermore, the presence of a subpopulation that
was endothelial (i.e. positive for CD31) but did not up-
regulate CD62E in response to TNFα suggests that the cells
in this subpopulation are pulmonary capillary endothelial
cells. Importantly this subpopulation was greater in the cells
isolated from patients with emphysema compared with
commercially available cells from Promocell used in the op-
timisation experiments. These pulmonary microvascular
endothelial cells may therefore provide a more appropriate
model than the current commercially available cells.
Infection is undoubtedly the major challenge to suc-
cessful isolation and investigation of human LMVECs.
Due to the inherent risks of infection whilst isolating the
cells, the lobe of lung was placed in media containing
1% PSA prior to processing. 1% PSA was included in all
MV2 media used in cell culture, the risk of infection
being deemed greater than any adverse effect on growth
kinetics the antimicrobials may have. In spite of this, a
number of cell cultures were lost to infection, mostly
around passage 6. With cell aging, growth kinetics reduced,
with greater time to confluence. Cells therefore spent a
longer time in culture with each successive passage, in-
creasing the likelihood of infection. Amphotericin was
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bacterial infections.
As with all ex vivo cell culture systems, inherent
limitations are associated. Cells were passaged 3–5 times
prior to obtaining pure cobblestone cultures which were
characterized as endothelial. Cells therefore have a pro-
tracted culture period, with possible associated increased
senescence and change in cell characteristic. Cells were
grown in MV2 media (Promocell) which included 5% fetal
calf serum supplementation and other survival factors
such as hydrocortisone (0.2 ug/ml), recombinant human
epidermal growth factor (5 ng/ml) fibroblast growth factor
(10 ng/ml) vascular endothelial growth factor (0.5 ng/ml)
and insulin like growth factor (Long R3) (20 ng/ml). The
addition of hydrocortisone to cell culture media has been
a contentious matter due to concerns over increased
cell stress and how this may change cellular physiology.
The concentration of hydrocortisone in MV2 media
(Promocell) is considerably lower than in other types of
microvascular endothelial cell media and its omission led
to cell death.
Finally, our method of cell isolation can be applied to
other respiratory diseases in which the pulmonary micro-
vasculature may be pivotal such as pulmonary arterial
hypertension and idiopathic pulmonary fibrosis. Indeed we
have successfully isolated large numbers of cells from these
pathologies (data not shown) with higher yields of cells at
lower passage than the emphysema model.
Conclusions
In conclusion, pulmonary microvasculature endothelial
cells can be isolated from severely emphysematous lungs
removed at transplantation with good success (71%). Full
characterisation of these cells confirms these to be of
high purity and of microvascular origin. Successful culture
yields large numbers of cells that can be cryopreserved
and later reanimated for use in mechanistic studies. We
propose that these cells provide a more biologically rele-
vant cell model for investigating the pulmonary micro-
vasculature and the pathogenesis of emphysema.
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